Jan 13 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Monday it has sued two medical spas for selling unapproved products claiming to contain tirzepatide, the main ingredient in its popular ...

That includes continuous glucose monitoring systems developed by Lilly's partner Dexcom as well as other manufacturers, as well as wearable devices from ... planners and medical affairs ...

Eli Lilly has expanded a collaboration with ... against rivals such as Apple and FitBit whose wearable devices have an increasing medical focus with tech like ECG readers. ActiGraph provides ...

Medical devices stocks are in a strong position “and must be bought,” according to Rich Ross, head of Technical Analysis at Evercore ISI, in a note. The iShares U.S. Medical Device ETF (NYSEARCA:IHI) ...

Lilly noted that the FDA decision ... patients not on a positive airway pressure (PAP) device that helps them when sleeping. ResMed Chief Medical Officer Carlos Nunez said that positive results ...

Seamless reading experience. Save your favourite. In an open letter, Lilly warned that unsafe or untested compounded tirzepatide puts patients at risk and that it stands against the use of its ...